Koronis: Developing a new treatment for HIV

I recently had the opportunity to conduct a brief interview with Jeff Parkins, Vice President of Clinical Development and Regulatory at Koronis on his company and the future of the biotechnology industry: Can you tell me a little bit about Koronis and its mission? Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration TM […]